PAR
Click for more information
3.77% 25.5¢ paradigm biopharmaceuticals limited..

New orphan drug designation, page-7

  1. Violin1
    1,254 Posts.
    lightbulb Created with Sketch. 286
    clock Created with Sketch.
    29/04/20
    20:57
    Post #: 44334900
    I think we still have to apply for the drug to be approved but this is step one (and perhaps encouragement by FDA to start down that track)?
    PAR Price at posting: $1.88 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢ 		Change
-0.010(3.77%) 		Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.